To verify the expression of LINC00969 in gefitinib resistant lung cancer, we collected 36 tissue specimens from patients with advanced NSCLC harbour EGFR exon 19 deletion (Exon 19 Del) or a point mutation in exon 21 (Exon 21 L858R). Here, EGFR is linked to lung cancer.